Skip to main content

Corporate Chronicles

Dive into the dynamic world of business with Corporate Chronicles, your go-to hub for in-depth case studies on influential business personalities, landmark mergers and acquisitions, and pivotal corporate events.

At Corporate Chronicles, we unravel the stories behind the headlines, providing detailed insights into the strategies, negotiations, and decisions that shape the global business landscape. From iconic leaders who have redefined industries to transformative mergers that have created market titans, our meticulously researched case studies offer a comprehensive understanding of the forces driving the corporate world.

Business Case Studies

Mergers and Acquisitions Case Studies

  1. How Mittal Steels acquire Arcelor 
  2. How L&T Infotech acquire Mindtree

Comments

Popular posts from this blog

Alivus Lifesciences Ltd: A Rising Star in the Pharma Industry?

Alivus Lifesciences (formerly knows as Glenmark Lifescience Ltd) is primarily engaged in Active Pharmaceutical Ingredient (API) manufacturing, serving both generic and innovator pharmaceutical companies. The company has a portfolio of high value, non-commoditized APIs in chronic therapeutic areas, namely Cardiovascular (CVS) disease, Central Nervous System (CNS) disorders, Pain Management, Oncology, Diabetes and Urology. History The company’s journey began over 22 years ago when Glenmark Pharmaceuticals (GPL) established its API (Active Pharmaceutical Ingredients) business. Initially, Glenmark acquired the Kurkumbh site to support its API needs. Over time, the API division expanded its R&D and operations to serve both Glenmark and external customers. In 2019, Glenmark Life Sciences became an independent company, separating from Glenmark Pharmaceuticals. This transition allowed GLS to focus solely on APIs, making it a trusted global supplier. The company began building a stro...

CPI Inflation Falls to 3.61% – Is a Rate Cut Coming

Inflation is extremely relevant to the economy of a country. It influences interest rates and the stock market. The February 2025 Consumer Price Index (CPI) report is out, and we see that inflation has fallen significantly. This blog tells us about the key points from the report, how various sectors are impacted, what the RBI can do, and how investors should interpret the numbers. Key CPI Inflation Highlights – February 2025 Overall Inflation Rate CPI Inflation (February 2025): 3.61% (Projected) CPI Inflation (Jan 2025): 4.26% CPI Inflation (Feb 2024): 5.49% This is a steep fall of 65 basis points (0.65%) from January 2025 and a yearly fall of 188 basis points (1.88%) from February 2024. This is the lowest inflation since July 2024. Food Price Inflation (CFPI - Consumer Food Price Index) February 2025: 3.75% January 2025: 5.97% February 2024: 9.24% Rural Food Inflation: 4.06% Urban Food Inflation: 3.20% Food inflation has decreased significantly by 222 basis points (2.22%) from Januar...

ETFs Explained: The Easiest Way to Diversify Your Investments

Investing can feel overwhelming, especially if you're unsure about picking individual stocks. That's where Exchange-Traded Funds (ETFs) come in. They offer a simple, cost-effective way to invest in a diversified basket of stocks, bonds, or commodities—all in one go. Whether you're a beginner or a seasoned investor, ETFs provide flexibility and ease of access to the market. But like any investment, they have their pros and cons. Let’s dive in to see if ETFs are the right fit for you. What is an ETF? An Exchange-Traded Fund (ETF) is like a mutual fund but trades on the stock market like a regular share. It holds a mix of assets—stocks, bonds, gold, or even real estate—and aims to track the performance of an index, sector, or commodity. The key advantage? You get exposure to multiple assets with a single investment. How Do ETFs Work? Imagine you want to invest in the Indian stock market but don’t want to research and pick individual stocks. You could simply buy a Nifty 50 ET...